155.14
Overview
News
Price History
Option Chain
Financials
Why LRCX Down?
Discussions
Forecast
Stock Split
Dividend History
Lam Research Corp stock is traded at $155.14, with a volume of 8.47M.
It is up +2.11% in the last 24 hours and up +2.28% over the past month.
Lam Research is one of the largest semiconductor wafer fabrication equipment manufacturers in the world. It specializes in deposition and etch, which entail the buildup of layers on a semiconductor and the subsequent selective removal of patterns from each layer. Lam holds the top market share in etch and holds the clear second share in deposition. It is more exposed to memory chipmakers for DRAM and NAND chips. It counts as top customers the largest chipmakers in the world, including TSMC, Samsung, Intel, and Micron.
See More
Previous Close:
$151.93
Open:
$152.965
24h Volume:
8.47M
Relative Volume:
0.74
Market Cap:
$194.86B
Revenue:
$19.59B
Net Income/Loss:
$5.81B
P/E Ratio:
34.19
EPS:
4.538
Net Cash Flow:
$5.55B
1W Performance:
+4.26%
1M Performance:
+2.28%
6M Performance:
+91.39%
1Y Performance:
+113.43%
Lam Research Corp Stock (LRCX) Company Profile
Name
Lam Research Corp
Sector
Phone
(510) 659-0200
Address
4650 CUSHING BLVD, FREMONT, CA
Compare LRCX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
LRCX
Lam Research Corp
|
155.14 | 190.83B | 19.59B | 5.81B | 5.55B | 4.538 |
|
ASML
Asml Holding Nv
|
1,040.97 | 389.40B | 35.54B | 10.43B | 9.71B | 26.71 |
|
AMAT
Applied Materials Inc
|
249.97 | 193.15B | 28.37B | 7.00B | 5.70B | 8.6769 |
|
KLAC
Kla Corp
|
1,159.07 | 150.56B | 12.52B | 4.24B | 3.87B | 31.85 |
|
TER
Teradyne Inc
|
179.38 | 26.26B | 2.83B | 469.17M | 568.90M | 2.8828 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-23-25 | Reiterated | TD Cowen | Buy |
| Sep-30-25 | Initiated | HSBC Securities | Hold |
| Sep-29-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-23-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-22-25 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Sep-02-25 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Aug-14-25 | Resumed | Erste Group | Buy |
| Jul-31-25 | Downgrade | Summit Insights | Buy → Hold |
| Jul-31-25 | Reiterated | TD Cowen | Buy |
| Jul-10-25 | Initiated | Goldman | Buy |
| Apr-24-25 | Reiterated | TD Cowen | Buy |
| Mar-20-25 | Resumed | Oppenheimer | Outperform |
| Feb-20-25 | Upgrade | Susquehanna | Neutral → Positive |
| Jan-30-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Jan-30-25 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Jan-17-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-15-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Dec-17-24 | Initiated | Cleveland Research | Neutral |
| Aug-01-24 | Reiterated | TD Cowen | Buy |
| May-13-24 | Initiated | Jefferies | Buy |
| Apr-25-24 | Reiterated | TD Cowen | Buy |
| Apr-19-24 | Upgrade | B. Riley Securities | Neutral → Buy |
| Apr-18-24 | Reiterated | Needham | Buy |
| Apr-16-24 | Initiated | Evercore ISI | Outperform |
| Apr-11-24 | Resumed | Deutsche Bank | Hold |
| Jan-25-24 | Reiterated | TD Cowen | Outperform |
| Jan-23-24 | Initiated | Cantor Fitzgerald | Neutral |
| Dec-12-23 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-08-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-22-23 | Initiated | Redburn Atlantic | Buy |
| Oct-17-23 | Initiated | Raymond James | Outperform |
| Oct-13-23 | Upgrade | Needham | Hold → Buy |
| Sep-15-23 | Initiated | Wolfe Research | Outperform |
| Jul-24-23 | Reiterated | Mizuho | Buy |
| Jul-24-23 | Upgrade | Stifel | Hold → Buy |
| Apr-20-23 | Reiterated | Berenberg | Buy |
| Apr-20-23 | Reiterated | Evercore ISI | Outperform |
| Apr-20-23 | Reiterated | JP Morgan | Overweight |
| Apr-20-23 | Reiterated | Jefferies | Buy |
| Apr-20-23 | Reiterated | Mizuho | Buy |
| Apr-20-23 | Reiterated | Stifel | Hold |
| Apr-20-23 | Reiterated | Wells Fargo | Equal Weight |
| Mar-13-23 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Jan-18-23 | Resumed | Stifel | Hold |
| Dec-12-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Oct-20-22 | Reiterated | B. Riley Securities | Neutral |
| Oct-20-22 | Reiterated | BofA Securities | Buy |
| Oct-20-22 | Reiterated | DA Davidson | Neutral |
| Oct-20-22 | Reiterated | Evercore ISI | Outperform |
| Oct-20-22 | Reiterated | JP Morgan | Overweight |
| Oct-20-22 | Reiterated | Jefferies | Buy |
| Oct-20-22 | Upgrade | Summit Insights | Hold → Buy |
| Oct-20-22 | Reiterated | Wells Fargo | Equal Weight |
| Jul-25-22 | Downgrade | Barclays | Overweight → Equal Weight |
| Jun-15-22 | Downgrade | B. Riley Securities | Buy → Neutral |
| Jan-27-22 | Reiterated | Barclays | Overweight |
| Jan-27-22 | Reiterated | Deutsche Bank | Hold |
| Jan-27-22 | Reiterated | Evercore ISI | Outperform |
| Jan-27-22 | Reiterated | Stifel | Buy |
| Jan-27-22 | Reiterated | Susquehanna | Neutral |
| Jan-27-22 | Reiterated | UBS | Buy |
| Jan-26-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jan-12-22 | Reiterated | Barclays | Overweight |
| Jan-10-22 | Reiterated | BofA Securities | Buy |
| Jan-05-22 | Resumed | Jefferies | Buy |
| Dec-15-21 | Reiterated | Deutsche Bank | Hold |
| Oct-21-21 | Reiterated | B. Riley Securities | Buy |
| Oct-21-21 | Downgrade | Summit Insights | Buy → Hold |
| Oct-15-21 | Initiated | Piper Sandler | Neutral |
| Sep-14-21 | Downgrade | Susquehanna | Positive → Neutral |
| Sep-07-21 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Jul-29-21 | Reiterated | Mizuho | Buy |
| Jul-29-21 | Reiterated | Stifel | Buy |
| Jul-29-21 | Reiterated | UBS | Buy |
| Jul-29-21 | Reiterated | Wells Fargo | Equal Weight |
| Mar-31-21 | Initiated | Bernstein | Outperform |
| Jan-28-21 | Reiterated | Cowen | Outperform |
| Jan-08-21 | Downgrade | Needham | Buy → Hold |
| Dec-17-20 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-22-20 | Reiterated | Goldman | Buy |
| Oct-22-20 | Reiterated | KeyBanc Capital Markets | Overweight |
| Oct-22-20 | Reiterated | Mizuho | Buy |
| Oct-22-20 | Reiterated | Morgan Stanley | Overweight |
| Oct-22-20 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-22-20 | Reiterated | Stifel | Buy |
| Oct-22-20 | Reiterated | UBS | Buy |
| Sep-21-20 | Upgrade | Stifel | Hold → Buy |
| Jul-30-20 | Reiterated | Cowen | Outperform |
| Jul-21-20 | Upgrade | B. Riley FBR | Neutral → Buy |
| Jun-22-20 | Downgrade | Stifel | Buy → Hold |
| Jun-16-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-26-20 | Initiated | Barclays | Overweight |
| Apr-23-20 | Reiterated | Needham | Buy |
| Apr-08-20 | Initiated | Exane BNP Paribas | Outperform |
| Apr-03-20 | Upgrade | Nomura | Neutral → Buy |
| Apr-02-20 | Downgrade | DA Davidson | Buy → Neutral |
| Mar-27-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Mar-27-20 | Upgrade | UBS | Sell → Buy |
View All
Lam Research Corp Stock (LRCX) Latest News
Lam Research: Fundamentals Remain Solid And I Remain Bullish - Seeking Alpha
Lam Research (NASDAQ:LRCX) Stock Price Up 2.1%Here's Why - MarketBeat
January 2026 Options Now Available For Lam Research (LRCX) - Nasdaq
Lam Research Corporation $LRCX Shares Sold by Himension Capital Singapore PTE. LTD. - MarketBeat
Lam Research Corporation $LRCX Shares Acquired by MIG Capital LLC - MarketBeat
Steward Partners Investment Advisory LLC Increases Holdings in Lam Research Corporation $LRCX - MarketBeat
This Is What Whales Are Betting On Lam Research - Benzinga
Waterloo Capital L.P. Buys New Shares in Lam Research Corporation $LRCX - MarketBeat
Lam Research Soars 109% YTD: Is LRCX Stock Still Worth Buying? - Finviz
FourThought Financial Partners LLC Lowers Stock Position in Lam Research Corporation $LRCX - MarketBeat
Oak Associates Ltd. OH Acquires 33,000 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Position Increased by Associated Banc Corp - MarketBeat
Lam Research Corp. Stock Climbs 5.4%, Outperforms Market - 富途牛牛
Lam Research (NASDAQ:LRCX) Trading Up 5.4% After Analyst Upgrade - MarketBeat
Lam Research Corp. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Prudential Financial Inc. Has $133.38 Million Stock Position in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Shares Bought by Charles Schwab Investment Management Inc. - MarketBeat
Atalanta Sosnoff Capital LLC Invests $65.45 Million in Lam Research Corporation $LRCX - MarketBeat
Bank Julius Baer & Co. Ltd Zurich Grows Position in Lam Research Corporation $LRCX - MarketBeat
What Are Wall Street Analysts’ Target Price for Lam Research Corporation Stock? - MSN
Coldstream Capital Management Inc. Has $16.05 Million Position in Lam Research Corporation $LRCX - MarketBeat
Stevens Capital Management LP Purchases New Stake in Lam Research Corporation $LRCX - MarketBeat
Richard W. Paul & Associates LLC Buys 1,779 Shares of Lam Research Corporation $LRCX - MarketBeat
Rhumbline Advisers Trims Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
Evelyn Partners Investment Management Services Ltd Buys 37,668 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Stake Increased by Franklin Resources Inc. - MarketBeat
Handelsbanken Fonder AB Cuts Holdings in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Stock Position Reduced by Personal CFO Solutions LLC - MarketBeat
ABN AMRO Bank N.V. Acquires Shares of 12,324 Lam Research Corporation $LRCX - MarketBeat
Lam Research opens $65 million office building in Oregon By Investing.com - Investing.com Nigeria
/C O R R E C T I O N -- Lam Research Corporation/ - Yahoo Finance
Lam Research (NASDAQ:LRCX) Trading 2.2% HigherShould You Buy? - MarketBeat
Lam Research Opens 120,000 SQFT Office Facility in Tualatin in to Accelerate Semiconductor Industry Leadership in AI Era - The Registry Pacific Northwest Real Estate
Lam Research opens $65M office in Oregon in response to expanding semiconductor demand - MSN
Lam Research unveils new Oregon facility as chipmaker rebounds from downturn - The Business Journals
Lam Research opens $65 million office building in Oregon - Investing.com
Lam Research opens $65 million office building in Tualatin, Oregon - StreetInsider
Lam Research opens $65M building in Tualatin, with more growth in the works - The Business Journals
Lam Research Corporation $LRCX Holdings Raised by Swiss National Bank - MarketBeat
JPMorgan Chase & Co. Purchases 5,102,589 Shares of Lam Research Corporation $LRCX - MarketBeat
The Zacks Analyst Blog Highlights Walmart, Intuitive Surgical, Lam Research and BV Financial - sharewise.com
DNB Asset Management AS Buys 566,754 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research (NASDAQ:LRCX) Trading Down 6.2%Here's What Happened - MarketBeat
Applied Materials: Up 40% in 2025 With Room to Run Long-Term - Investing.com
GDS Wealth Management Buys 32,930 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research Corp. stock outperforms competitors on strong trading day - MarketWatch
Top Stock Reports for Walmart, Intuitive Surgical & Lam Research - Yahoo Finance
Lam Research Corporation stock volume spike explainedWeekly Trade Analysis & Consistent Growth Stock Picks - newser.com
Frank Rimerman Advisors LLC Sells 18,181 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research Corp. Opens with a 5.12% Gain Amid Market Decline - Markets Mojo
ARS Investment Partners LLC Acquires 4,504 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research Corp Stock (LRCX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):